CorMedix Inc. — Income Charts
52 quarters of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Revenue, Gross Profit, Operating Income & Net Income
Margin (%)
Operating Expenses
Income Breakdown
Revenue↑+312.1% +$97M
$129M
Cost of Revenue↑+995.9% +$10M
$11M
Gross Profit↑+263.6% +$78M
$107M
R&D↑+398.1% +$7M
$9M
SG&A↑+97.8% +$7M
$15M
D&A↑+259.6% +$212K
$294K
Operating Income
$59M
EBITDA↑+72549.9% +$59M
$59M
Interest Expense↑+18824.0% +$2M
$2M
Interest Income↑+74.3% +$379K
$890K
Other Income/Expense
$-2M
Pretax Income
$56M
Tax Provision
$42M
Net Income
$14M
Gross Margin↓-11.1pts
83.4%
Operating Margin
46.0%
Net Margin
10.9%
Effective Tax Rate
75.2%
Deferred Tax Assets
$53M
DTA Valuation Allowance
$280M
ETR (Continuing Operations)↓-15.9pts
-8.7%
ETR Federal Statutory↑+0.0pts
21.0%
ETR State + Local (pp)↓-0.3pts
6.9%
ETR Foreign Differential (pp)↑+0.3pts
0.0%
Operating Lease Cost↑+100.5% +$51K
$101K
Revenue YoY Variation
312.1%
Income YoY Variation↑+1593.3pts
1661.9%
Revenue QoQ Variation↓-149.1pts
23.3%
Income QoQ Variation
15.2%